In conclusion, our study provides evidence that the down-regulation of SFMBT2 promotes prostate cancer metastasis by the recruitment of preadipocytes and TAMs through NF-κB-dependent up-regulation of chemokine expression (Figure 7). The gene discussed is SFMBT2; the disease is prostate carcinoma.